Generate a tailored SOP for Dr. Paul Martin. Improve your application with a focused, well-structured draft.
Paul Langlie Martin is a Professor Emeritus in the Department of Pediatrics with a focus on Pediatric Hematology/Oncology. His clinical expertise centers on the use of stem cell transplant treatments for pediatric leukemias, including Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML), Juvenile Myelomonocytic Leukemia (JMML), as well as non-malignant blood disorders like sickle cell disease and various inherited metabolic diseases. He has led clinical research aimed at minimizing transplant-related morbidities, particularly veno-occlusive disease of the liver and infections. Dr. Martin serves as a study chair for the Children’s Oncology Group protocol 9904 and has contributed to large-scale studies exploring childhood acute lymphoblastic leukemia treatments. His commitment to high-quality care for high-risk leukemia patients involves the use of intensive therapies, stem cell transplants, and immunotherapy.
Duke University • Durham, NC
Retired faculty member focusing on pediatric hematology and oncology.
Duke University • Durham, NC
Led the division specializing in transplant procedures and patient care.
Duke University • Durham, NC
Taught and conducted research in pediatric hematology.
Duke University • Durham, NC
Engaged in teaching and research in the Department of Pediatrics.
Duke University • Durham, NC
Temporary faculty position teaching pediatric courses.
Department of Biomedical Engineering (MS program)